Nova Leah is the leader in Cyber Security for Medical Devices
- Connected medical devices are vulnerable to cyber attacks that could kill the patient and be used as a gateway into hospital networks.
- The Founder of the company developed the IEEE specifications that are the basis of new regulation in China and the USA (FDA) for medical device cyber security.
- She then went on to develop SelectEvidence ®, an expert cybersecurity risk analysis system, the first of its kind, providing medical device manufacturers with an automated solution for implementing and maintaining cybersecurity requirements across medical device product portfolios.
- The company has significant recurring revenue sales contracts with key medical device manufacturers in the USA.
Founder: Anita Finnigan